August 26, 2016
Aveo Pharmaceuticals Inc.'s board has agreed to reform itself and the company's internal policies following an investor's derivative suit claiming it lied about the success of a clinical trial for a kidney cancer medication, according to a preliminary settlement submitted Thursday to a Massachusetts federal court.
April 29, 2015
Board members at Aveo Pharmaceuticals Inc. dodged a derivative suit Tuesday when a Massachusetts federal judge ruled that the plaintiff didn't back her claims that the board was liable and should have taken her complaints about the company's kidney cancer drug tivozanib to them first.